Umeno R - Search Results

1

Activation of the inflammasome drives peritoneal deterioration in a mouse model of peritoneal fibrosis.

Kadoya H, Hirano A, Umeno R, Kajimoto E, Iwakura T, Kondo M, Wada Y, Kidokoro K, Kishi S, Nagasu H, Sasaki T, Taniguchi S, Takahashi M, Kashihara N. Kadoya H, et al. Among authors: umeno r. FASEB J. 2023 Sep;37(9):e23129. doi: 10.1096/fj.202201777RRR. FASEB J. 2023. PMID: 37606578

2

Endothelial Dysfunction Accelerates Impairment of Mitochondrial Function in Ageing Kidneys via Inflammasome Activation.

Wada Y, Umeno R, Nagasu H, Kondo M, Tokuyama A, Kadoya H, Kidokoro K, Taniguchi S, Takahashi M, Sasaki T, Kashihara N. Wada Y, et al. Among authors: umeno r. Int J Mol Sci. 2021 Aug 27;22(17):9269. doi: 10.3390/ijms22179269. Int J Mol Sci. 2021. PMID: 34502177 Free PMC article.

3

Insights into the Regulation of GFR by the Keap1-Nrf2 Pathway.

Kidokoro K, Kadoya H, Cherney DZI, Kondo M, Wada Y, Umeno R, Kishi S, Nagasu H, Nagai K, Suzuki T, Sasaki T, Yamamoto M, Kanwar YS, Kashihara N. Kidokoro K, et al. Among authors: umeno r. Kidney360. 2023 Oct 1;4(10):1454-1466. doi: 10.34067/KID.0000000000000171. Epub 2023 Jun 2. Kidney360. 2023. PMID: 37265366 Free PMC article.

4

Empagliflozin in Patients with Chronic Kidney Disease.

The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R. The EMPA-KIDNEY Collaborative Group, et al. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. N Engl J Med. 2023. PMID: 36331190 Free PMC article. Clinical Trial.

5

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.

EMPA-KIDNEY Collaborative Group. EMPA-KIDNEY Collaborative Group. Lancet Diabetes Endocrinol. 2024 Jan;12(1):51-60. doi: 10.1016/S2213-8587(23)00322-4. Epub 2023 Dec 4. Lancet Diabetes Endocrinol. 2024. PMID: 38061372 Free article. Clinical Trial.

6

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.

EMPA-KIDNEY Collaborative Group. EMPA-KIDNEY Collaborative Group. Lancet Diabetes Endocrinol. 2024 Jan;12(1):39-50. doi: 10.1016/S2213-8587(23)00321-2. Epub 2023 Dec 4. Lancet Diabetes Endocrinol. 2024. PMID: 38061371 Free PMC article. Clinical Trial.

7

The effects of BPA-BNCT on normal bone: determination of the CBE value in mice‡.

Iwasaki R, Yoshikawa R, Umeno R, Seki A, Matsukawa T, Takeno S, Yokoyama K, Mori T, Suzuki M, Ono K. Iwasaki R, et al. Among authors: umeno r. J Radiat Res. 2023 Sep 22;64(5):795-803. doi: 10.1093/jrr/rrad054. J Radiat Res. 2023. PMID: 37517393 Free PMC article.

8

CLINICAL STUDY ON ANISEIKONIA.

UMENO R. UMENO R. Kyushu J Med Sci. 1963 Jun;14:145-56. Kyushu J Med Sci. 1963. PMID: 14056542 No abstract available.

9

[Contact lens in unilateral aphakia].

UMENO R. UMENO R. Rinsho Ganka. 1962 Apr;16:527-30. Rinsho Ganka. 1962. PMID: 13923767 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page